share_log

中基長壽科學:董事名單與其角色和職能

ZHONG JI LS: LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

HKEX ·  Jul 10 07:57

Summary by Moomoo AI

中基長壽科學集團有限公司於2024年7月10日公布了其董事會成員名單,包括執行董事閆立先生擔任主席,閆一帆先生為行政總裁,以及李小雙先生和曹衆女士。公司亦指定了非執行董事何亦武博士和呂長勝先生,以及三位獨立非執行董事:李思先生、黃江先生和黃慈波教授。此外,董事會下設五個委員會,包括審核委員會、提名委員會、薪酬委員會、風險管理委員會和股份獎勵委員會,並公布了各委員會的成員組合。公告指出,如中英文版本有歧義,一律以英文版本為準。
中基長壽科學集團有限公司於2024年7月10日公布了其董事會成員名單,包括執行董事閆立先生擔任主席,閆一帆先生為行政總裁,以及李小雙先生和曹衆女士。公司亦指定了非執行董事何亦武博士和呂長勝先生,以及三位獨立非執行董事:李思先生、黃江先生和黃慈波教授。此外,董事會下設五個委員會,包括審核委員會、提名委員會、薪酬委員會、風險管理委員會和股份獎勵委員會,並公布了各委員會的成員組合。公告指出,如中英文版本有歧義,一律以英文版本為準。
Zhong Ji Longevity Science Group Co., Ltd. announced its board of directors on July 10, 2024, including Executive Director Mr. Yan Lixian as chairman, Mr. Yan Yifan as CEO, and Mr. Li Xiaoshuang and Ms. Cao Zhong. The company also appointed non-executive directors Dr. He Yiwu and Mr. Lu Changsheng, as well as three independent non-executive directors: Mr. Li Si, Mr. Huang Jiang and Professor Huang Cibo. In addition, the board of directors has five committees, including the audit committee, nomination committee, compensation committee, risk management committee, and stock incentive committee, and has announced the composition of each committee. The announcement stated that in case of discrepancies between the Chinese and English versions, the English version shall prevail.
Zhong Ji Longevity Science Group Co., Ltd. announced its board of directors on July 10, 2024, including Executive Director Mr. Yan Lixian as chairman, Mr. Yan Yifan as CEO, and Mr. Li Xiaoshuang and Ms. Cao Zhong. The company also appointed non-executive directors Dr. He Yiwu and Mr. Lu Changsheng, as well as three independent non-executive directors: Mr. Li Si, Mr. Huang Jiang and Professor Huang Cibo. In addition, the board of directors has five committees, including the audit committee, nomination committee, compensation committee, risk management committee, and stock incentive committee, and has announced the composition of each committee. The announcement stated that in case of discrepancies between the Chinese and English versions, the English version shall prevail.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more